Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2015-04-07A Study of Strategies to Improve Schizophrenia Treatment
-
CLINICAL_TRIALS study record update · 2015-04-07Improving Health Services for Veterans With Schizophrenia
-
CLINICAL_TRIALS study record update · 2015-04-07Improving Antipsychotic Adherence Among Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2015-04-07Clozapine or Haloperidol in First Episode Schizophrenia
-
CLINICAL_TRIALS study record update · 2015-04-07Clozapine vs. Olanzapine: An Effectiveness Study
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2015-04-07Clozapine Response and Biogenic Amines in Schizophrenia
-
CLINICAL_TRIALS study record update · 2015-04-07A Multi-Site Study of Strategies for Implementing Schizophrenia Guidelines
-
CLINICAL_TRIALS study record update · 2015-04-07Psychiatric Advance Directives for Improved Healthcare
-
CLINICAL_TRIALS study record update · 2015-04-06Functional Rehabilitation of Older Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2015-04-03Risperidone Effects On Frontal And Temporal Cortical Function In Schizophrenia Patients Undergoing FMRI Cognitive Task Performance
-
CLINICAL_TRIALS study record update · 2015-04-02A Long-Term Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aripiprazole (OPC 14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2015-04-01Multisite Double-Blind Randomized Controlled Study of Estradiol Plus Antipsychotic Versus Placebo Plus Antipsychotic in the Treatment of Psychotic Symptoms in Women With Schizophrenia
-
CLINICAL_TRIALS study record update · 2015-04-01Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia
-
CLINICAL_TRIALS study record update · 2015-03-31A 26-week, Multicenter, Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2015-03-27Open-label Study to Assess Hospitalization Rates in Adult Schizophrenic Patients Treated With Oral Antipsychotics for 6 Months and IM Depot Aripiprazole for 6 Months, Respectively, in a Naturalistic Community Setting
-
CLINICAL_TRIALS study record update · 2015-03-25L-Arginine add-on Treatment for Schizophrenia: A Randomized, Double Blind, Placebo Controlled, Cross Over Study
-
CLINICAL_TRIALS study record update · 2015-03-17Olanzapine in Standard Clinical Practice. 6-month Efficacy and Safety Monitoring
-
CLINICAL_TRIALS study record update · 2015-03-17Cardiac Coherence Training to Reduce Anxiety in Remitted Schizophrenia
-
CLINICAL_TRIALS study record update · 2015-03-11A Long-term, Multicenter, Open-Label, Flexible Dose Continuation Study in Subjects Who Have Completed a Prior Lurasidone Study
-
CLINICAL_TRIALS study record update · 2015-03-10Electromyography Study of Lip Muscles During Auditory Verbal Hallucinations Without Subvocalization in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2015-03-06Interventional, Randomised, Double-blind, Placebo-controlled, Sequential Group, Multiple Dose Study Investigating the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of Lu AF35700 in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2015-03-06Interventional, Open-label, Part Fixed Sequence, Part-randomised Study Investigating the Pharmacokinetic Properties of up to 6 Prototype Modified Release Tablet Formulations of Lu AF11167 in Healthy Young Subjects
-
CLINICAL_TRIALS study record update · 2015-03-04A Randomized, Open-Label, Parallel-Group Study to Assess the Relative Bioavailability of LY03004 and Risperdal® Consta® at 25 mg Following Multiple Intramuscular Injections in Stable Patients With Schizophrenia or Schizoaffective Disorder
-
CLINICAL_TRIALS study record update · 2015-03-04Pharmacologic and Clinical Testing of a D1 Agonist for Cognitive Enhancement in Neuropsychiatric Disorders
-
CLINICAL_TRIALS study record update · 2015-03-03Metacognitive Training (MCT) Compared With Cognitive Remediation (CR) in Schizophrenia: a Randomized Controlled Study Over 4 Weeks